| Cancer-related stroke | Controls | p value |
---|---|---|---|
n (%) or mean ± SD or median (IQR) | n (%) or mean ± SD or median (IQR) | ||
Total | 34 (100%) | 307 (100%) | Â |
Time variable | |||
 Onset-to-puncture time, min | 327.5 (170.25–507.5) | 330 (185–602.5) | 0.751 |
 Puncture-to-reperfusion time, min | 66.5 (42.5–90.5) | 60 (41–90) | 0.784 |
Radiological outcomes | |||
 Reperfusion status |  |  | 0.758 |
  mTICI 0, 1 | 2 (5.9%) | 15 (4.9%) |  |
  mTICI 2a | 5 (14.8%) | 23 (7.5%) |  |
  mTICI 2b | 14 (41.2%) | 112 (36.5%) |  |
  mTICI 3 | 13 (38.2%) | 157 (51.1%) |  |
 Successful recanalization | 26 (76.5%) | 269 (87.6%) | 0.103 |
 Any cerebral hemorrhage | 14 (41.2%) | 73 (23.8%) | 0.037 |
  HBC Class 1a | 0 | 4 |  |
  HBC Class 1b | 2 | 21 |  |
  HBC Class 1c | 3 | 18 |  |
  HBC Class 2 | 7 | 25 |  |
  HBC Class 3a | 0 | 0 |  |
  HBC Class 3b | 0 | 0 |  |
  HBC Class 3c | 2 | 5 |  |
  HBC Class 3d | 0 | 0 |  |
Craniectomy | 3 (21.4%) | 18 (24.6%) | 0.452 |
Clinical outcomes | |||
 NIHSS score at discharge | 13 (8–30) | 5 (2–12.5) | < 0.001 |
 mRS score at discharge | 5 (3–5) | 3 (1–5) | 0.044 |
 mRS score at 3 months | 4 (2–5.25) | 3 (1–4) | 0.026 |
 Mortality during the hospitalization | 7 (20.6%) | 18 (5.9%) | 0.009 |
 Mortality at 3 months | 9 (26.5%) | 21 (6.8%) | < 0.001 |
 Causes of death at 3 months |  |  | 0.687 |
  Stroke | 7 | 15 |  |
  Sepsis | 1 | 3 |  |
  Progression of cancer | 1 | 0 |  |
  Others | 0 | 3 |  |